Patents by Inventor Ashraf Virmani

Ashraf Virmani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition useful as a dietary supplement
    Patent number: 10076541
    Abstract: Compositions comprising L-carnitine or a salt thereof, acetyl L-carnitine or a salt thereof, vitamin B9 (folic Acid), vitamin A, vitamin B12, vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), arginine, vitamin C, vitamin E (?-Tocopherol), selenium, zinc, copper, iron, vitamin D and N-acetyl cysteine, and optionally one or more pharmaceutically acceptable excipients are provided. Dietary supplements comprising these compositions are also provided.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: September 18, 2018
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Ashraf Virmani, Safouane Zerelli
  • Composition Useful for Promoting Female Fertility
    Publication number: 20160303164
    Abstract: Here is described a synergystic composition for promoting female fertility, comprising as active ingredients L-carnitine, acetyl L-carnitine; N-acetyl cysteine, and several specific vitamins, aminoacids, antioxidants and micro elements.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 20, 2016
    Applicant: SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Ashraf VIRMANI, Safouane ZERELLI
  • Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
    Patent number: 9457037
    Abstract: A combination composition comprising as active ingredients L-carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: October 4, 2016
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Mohamed Ashraf Virmani, Aleardo Koverech
  • Composition useful for the treatment of lipid metabolism disorders
    Patent number: 9125903
    Abstract: The present invention relates to a composition useful for the treatment of lipid metabolism disorders, comprising one or more of the following active ingredients: (a) extract of rice fermented with Monascus purpureus, (b) at least one omega-3 fatty acid, (c) L-carnitine or a salt thereof; and one or more of the following active ingredients: (d) at least one policosanol or a natural extract containing policosanols; (e) resveratrol or a natural extract containing resveratrol; (f) Coenzyme Q10; and (g) at least one vitamin.
    Type: Grant
    Filed: April 24, 2012
    Date of Patent: September 8, 2015
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A.
    Inventors: Aleardo Koverech, Ashraf Virmani
  • Composition useful for the prevention or reduction of the progression of prostate cancer
    Patent number: 9084812
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: July 21, 2015
    Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A
    Inventors: Franco Gaetani, Ashraf Virmani
  • COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20150045424
    Abstract: It is described the use of L-carnitine and/or an alkanoyl L-carnitine, or a pharmaceutically acceptable salt thereof, in combination with a statin, for the preparation of a medicament for the treatment of type 2 diabetes.
    Type: Application
    Filed: October 28, 2014
    Publication date: February 12, 2015
    Inventors: Franco GAETANI, Ashraf VIRMANI
  • COMPOSITION FOR TIPICAL USE FOR TREATING SKIN DISORDERS
    Publication number: 20140294921
    Abstract: It is described a composition, topically administrable, comprising as active ingredients L-carnitine or a derivative thereof, biotin, and at least one or more of the following active ingredients: vitamin B 12; vitamin E; bisabolol; and panthenol; useful for treating skin disorders.
    Type: Application
    Filed: November 28, 2011
    Publication date: October 2, 2014
    Applicant: SIGMA-TAU INDUSTRIE FAMACEUTICHE RIUNITE S.P.A.
    Inventors: Aleardo Koverech, Ashraf Virmani
  • COMPOSITION USEFUL FOR THE PREVENTION OR REDUCTION OF THE PROGRESSION OF PROSTATE CANCER
    Publication number: 20140255512
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Application
    Filed: May 23, 2014
    Publication date: September 11, 2014
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco GAETANI, Ashraf VIRMANI
  • Composition useful for the prevention or reduction of the progression of prostate cancer
    Patent number: 8758835
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: June 24, 2014
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • COMPOSITION USEFUL FOR THE TREATMENT OF LIPID METABOLISM DISORDERS
    Publication number: 20140086985
    Abstract: The present invention relates to a composition useful for the treatment of lipid metabolism disorders, comprising one or more of the following active ingredients: (a) extract of rice fermented with Monascus purpureus, (b) at least one omega-3 fatty acid, (c) L-carnitine or a salt thereof; and one or more of the following active ingredients: (d) at least one policosanol or a natural extract containing policosanols; (e) resveratrol or a natural extract containing resveratrol; (f) Coenzyme Q10; and (g) at least one vitamin.
    Type: Application
    Filed: April 24, 2012
    Publication date: March 27, 2014
    Applicant: SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Ashraf Virmani
  • COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
    Publication number: 20140018310
    Abstract: A combination composition comprising as active ingredients L-carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
    Type: Application
    Filed: September 19, 2013
    Publication date: January 16, 2014
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Mohamed Ashraf Virmani, Aleardo Koverech
  • COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
    Publication number: 20130005670
    Abstract: It is described a combination composition comprising as active ingredients L-carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
    Type: Application
    Filed: February 7, 2011
    Publication date: January 3, 2013
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Mohamed Ashraf Virmani, Aleardo Koverech
  • COMPOSITION USEFUL FOR THE PREVENTION OR REDUCTION OF THE PROGRESSION OF PROSTATE CANCER
    Publication number: 20110262417
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Application
    Filed: July 24, 2009
    Publication date: October 27, 2011
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
    Publication number: 20110189152
    Abstract: A combination composition comprising as active ingredients L-carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
    Type: Application
    Filed: February 7, 2011
    Publication date: August 4, 2011
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Mohamed Ashraf Virmani, Aleardo Koverech
  • COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20100029759
    Abstract: It is described the use of L-canitine and/or an alkanoyl L-canitine, or a pharmaceutically acceptable salt thereof, in combination with a statin, for the preparation of a medicament for the treatment of type 2 diabetes.
    Type: Application
    Filed: November 20, 2007
    Publication date: February 4, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Franco Gaetani, Ashraf Virmani